Tedec-Meiji Farma, S.A.   Report issue

For profit Phase 3 Phase 4
Founded: Henares Spain (1944)
Status: No NME R&D (1944)

Organization Overview

First Clinical Trial
2007
NCT00598403
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

hyaluronic acid (1 trial)

Drugs in Phase 3 Trials (4)

cefditoren (spectracef) (1 trial)

chondroitin (1 trial)

ciprofloxacin (cipro) (1 trial)

glucosamine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystitis (Phase 3)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5